Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
S7VR2sbXHj0XfeZS